North America was Bio Key International’s largest region in fiscal 2025, bringing in $2.67M of $5.94M (45%).
| Geography | FY 2017 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| North America | $3.55M | $3.24M | $3.46M | $2.67M | ||||
| Emesa | $2.58M | $3.80M | $1.72M | $2.25M | ||||
| Africa | — | $654.45K | $1.65M | $781.77K | ||||
| Emea | — | — | — | — | ||||
| Asia | $264.51K | $67.84K | $91.31K | $232.26K | ||||
| South America | $626.30K | — | — | — | ||||
| Total | $7.02M | $7.75M | $6.93M | $5.94M |
Bio Key International brought in $5.94M from its four regions in fiscal 2025, the year ended December 31, 2025. That was down 14.3% from $6.93M in fiscal 2024. North America was the largest at $2.67M (45.0%), ahead of Emesa at $2.25M (37.9%) and Africa at $781.77K (13.2%). The remaining region, Asia, brought in $232.26K.
Compared with fiscal 2024, Asia grew fastest, up 154.4% to $232.26K, while Africa fell the most, down 52.7% to $781.77K.
Bio Key International stopped reporting South America as a separate region after fiscal 2022, when it brought in $626.30K.
License was Bio Key International’s largest product and service line in fiscal 2025, bringing in $3.42M of $5.94M (58%).
| Product and Service | FY 2017 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 |
|---|---|---|---|---|---|---|---|---|
| License Fees & Other | — | — | — | — | ||||
| License | $4.58M | $4.34M | $5.19M | $3.42M | ||||
| Service | $1.79M | $2.22M | $1.11M | $1.17M | ||||
| Hardware | $646.49K | $1.19M | $631.70K | $1.34M | ||||
| Professional Services | — | — | — | — | ||||
| Maintenance | — | — | — | — | ||||
| Total | $7.02M | $7.75M | $6.93M | $5.94M |
Bio Key International brought in $5.94M from its three product and service lines in fiscal 2025, the year ended December 31, 2025. That was down 14.3% from $6.93M in fiscal 2024. License was the largest at $3.42M (57.7%), ahead of Hardware at $1.34M (22.6%) and Service at $1.17M (19.7%).
Compared with fiscal 2024, Hardware grew fastest, up 112.5% to $1.34M, while License fell the most, down 34.0% to $3.42M. From fiscal 2022 to 2025, combined revenue from these lines fell from $7.02M to $5.94M, a compound annual decline of 5.4%. License's share of the total fell from 65.3% to 57.7%.
Bio Key International (BKYI) reports its revenue by geography and by product and service. In fiscal 2025, North America was its largest region, bringing in $2.67M (45.0% of the total), followed by Emesa at $2.25M (37.9%).
North America was Bio Key International's largest region in fiscal 2025, bringing in $2.67M, or 45.0% of the $5.94M total across its four regions.
License was Bio Key International's largest product and service line in fiscal 2025, bringing in $3.42M, or 57.7% of the $5.94M total across its three product and service lines.
Among Bio Key International's regions that make up at least 2% of revenue, Asia grew fastest in fiscal 2025, up 154.4% from $91.31K to $232.26K.
Every figure comes from Bio Key International's annual financial filings, as reported. Each line keeps the name Bio Key International gives it, and years follow its fiscal calendar.
Bio Key International's revenue by geography goes back to fiscal 2017, with figures through fiscal 2025. The latest four fiscal years are free to view, and the full history is available with a Business Quant subscription.